Science Explorer Interactive view Map
Company · London · United Kingdom

Astellas Pharma (United Kingdom)

In research, Astellas Pharma (United Kingdom) stands highest in Medicine (#6,638 of 17,978 worldwide) and Health Sciences (#8,837 of 20,462 worldwide), over all time.

astellas.co.ukROR OpenAlex
World rank, all time
#24,283
of 42,892
Rank in United Kingdom
#1,300
of 2,253
Research works
194
▼ 61% vs 2013–17
Citations
3.4k
17.6 per fractional work
Top-10% rate
12.8%
record average 16.5%
Open access
50%
world 28%

What is Astellas Pharma (United Kingdom) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #6,638 of 17,978 16.5%143
Health SciencesDomain #8,837 of 20,462 16.2%147

Each strip is that field’s whole ranked pool, with the notch where Astellas Pharma (United Kingdom) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.63× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 2.35× its world share, 1 worksImmunology and Micro…Neuroscience: 0.38× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.73× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.35× its world share, 1 worksComputer ScienceMathematics: 3.31× its world share, 1 worksMathematicsDentistry: 2.47× its world share, 0 worksDentistryHealth Professions: 0.60× its world share, 0 worksHealth ProfessionsMedicine: 3.56× its world share, 24 worksMedicineArts and Humanities: 0.11× its world share, 0 worksArts and HumanitiesDecision Sciences: 1.89× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 2.54× its world share, 2 worksEconomics, Econometr…Psychology: 0.37× its world share, 0 worksPsychologySocial Sciences: 0.06× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.6×. Every wedge is a field page.

Who are the top researchers at Astellas Pharma (United Kingdom)?

Ranked on the composite score, Emad Siddiqui, Isaac Odeyemi and Jameel Nazir lead among researchers whose main affiliation is Astellas Pharma (United Kingdom).

  1. 1 Emad Siddiqui United Kingdom · #802,181 worldwide 31 citations · 16 works
  2. 2 Isaac Odeyemi United Kingdom · #1,470,553 worldwide 10 citations · 22 works
  3. 3 Jameel Nazir United Kingdom · #1,524,153 worldwide 8 citations · 17 works
All ranked researchers at Astellas Pharma (United Kingdom)

Which keywords describe research at Astellas Pharma (United Kingdom)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cardiovascular Disease, Hormone Therapy, Breast Cancer, Quality of Life, Immunotherapy, Depression, Chronic Kidney Disease and Menopause.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cardiovascular Disease5▲ 14×7 topics
  2. Hormone Therapy4▲ 141×3 topics
  3. Quality of Life3▲ 6.7×9 topics
  4. Breast Cancer3▲ 38×7 topics
  5. Immunotherapy3▲ 12×8 topics
  6. Depression3▲ 9.6×4 topics
  7. Chronic Kidney Disease3▲ 32×4 topics
  8. Epidemiology3▲ 1.98×15 topics
  9. Menopause3▲ 167×2 topics
  10. Chemotherapy3▲ 11×10 topics
  11. Anemia2▲ 77×3 topics
  12. Estrogen2▲ 189×2 topics
  13. Cancer Treatment2▲ 29×4 topics
  14. Cognitive Function2▲ 38×3 topics
  15. Iron Deficiency2▲ 133×2 topics
  16. Biomarkers2▲ 9.2×4 topics
  17. Stroke2▲ 34×3 topics
  18. Bone Mineral Density2▲ 80×1 topic
  19. Clinical Trials2▲ 8.4×4 topics
  20. Ovarian Cancer2▲ 66×2 topics
  21. Vasomotor Symptoms2▲ 334×1 topic
  22. Neoadjuvant Therapy2▲ 23×3 topics
  23. Prostate Cancer2▲ 42×3 topics
  24. Erythropoiesis-Stimulating Agents2▲ 410×1 topic
  25. Heart Failure2▲ 12×1 topic
  26. Molecular Characterization2▲ 29×3 topics
  27. Neuroprotection2▲ 15×2 topics
  28. Bladder Cancer2▲ 120×1 topic
  29. Guidelines2▲ 10.0×2 topics
  30. Urothelial Carcinoma2▲ 104×1 topic
  31. Diabetes2▲ 8.5×4 topics
  32. Cardiovascular Risk1▲ 13×2 topics
  33. Genetic Mutations1▲ 9.3×6 topics
  34. Bayesian Methods1▲ 72×2 topics
  35. Cost-effectiveness Analysis1▲ 41×1 topic
  36. Health Utility Measures1▲ 41×1 topic
  37. Adaptive Designs1▲ 161×1 topic
  38. False Discovery Rate1▲ 161×1 topic
  39. Aging Men1▲ 124×1 topic
  40. Testosterone1▲ 70×1 topic

Which research topics does Astellas Pharma (United Kingdom) publish most on?

By volume in 2022–2025: Menopause: Health Impacts and Treatments, Erythropoietin and Anemia Treatment, Bladder and Urothelial Cancer Treatments and Health Systems, Economic Evaluations, Quality of Life.

Menopause: Health Impacts and Treatments: 2 fractional worksErythropoietin and Anemia Treatment: 2 fractional worksBladder and Urothelial C…2Bladder and Urothelial Cancer Treatments: 2 fractional worksHealth Systems, Economic…1Health Systems, Economic Evaluations, Quality of Life: 1 fractional worksStatistical Methods in Clinical Trials: 1 fractional worksHormonal and reproductive studies: 1 fractional worksProstate Cancer Treatmen…1Prostate Cancer Treatment and Research: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksProstate Cancer Diagnosis and Treatment: 1 fractional worksSexual function and dysfunction studies: 1 fractional works
Endocrinology, Diabetes and MetabolismHematologySurgeryEconomics and Econometrics4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Menopause: Health Impacts and Treatments Endocrinology, Diabetes and Metabolism 2 works
  2. 2 Erythropoietin and Anemia Treatment Hematology 2 works
  3. 3 Bladder and Urothelial Cancer Treatments Surgery 2 works
  4. 4 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  5. 5 Statistical Methods in Clinical Trials Statistics and Probability 1 works
  6. 6 Hormonal and reproductive studies Endocrinology, Diabetes and Metabolism 1 works
  7. 7 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
  8. 8 Cancer Immunotherapy and Biomarkers Oncology 1 works
  9. 9 Prostate Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
  10. 10 Sexual function and dysfunction studies Psychiatry and Mental health 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.6%not open50.4%

World: 28% of research is openly available.

with international co-authors60.4%domestic only39.6%

World: 19% is written across borders.

How has Astellas Pharma (United Kingdom)'s research output changed?

Output in 2018–2022 was 61% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in London

All research institutions in London

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.